Background: Highly potent toxins such as tetrodotoxin that block sodiu
m channels with great specificity have been studied for many years and
can provide prolonged blockade when coadministered with vasoconstrict
ors or conventional local anesthetics. Their utility has been constrai
ned, however, by systemic toxicity. The authors examined the efficacy
of tetrodotoxin with and without epinephrine or bupivacaine for produc
ing prolonged-duration sciatic nerve blockade in the rat, and they ass
essed the degree of concomitant toxicity, Methods: Rats received percu
taneous sciatic nerve blockade using tetrodotoxin with and without epi
nephrine or bupivacaine. A subset received subcutaneous injections at
the nuchal midline, Nociceptive, proprioceptive, and motor blockade we
re quantified using contralateral leg responses as controls for system
ic effects. Results: Tetrodotoxin without epinephrine produced sciatic
nerve blockade, but with considerable toxicity at most effective dose
s. Epinephrine reduced the median effective concentration of tetrodoto
xin for nociception from 37.6 to 11.5 mu M and prolonged its duration,
such that reversible blocks lasting >13 h were achieved. Epinephrine
reduced measures of systemic distribution and increased the median let
hal dose of tetrodotoxin from 40 to 53.6 nmole/kg, thus more than quad
rupling the therapeutic index. Bupivacaine increased the local anesthe
tic potency of tetrodotoxin, reduced its systemic toxicity, and, when
coinjected subcutaneously, increased the median lethal dose from 43.7
to 47.7 nmole/kg, The addition of epinephrine did not further improve
the effectiveness of the bupivacaine-tetrodotoxin combination. Conclus
ion: Combinations of epinephrine or bupivacaine with tetrodotoxin or w
ith other high-potency toxins active on sodium channels should be exam
ined for the potential to provide clinically useful, prolonged nerve b
lockade.